Post by Alnylam Pharmaceuticals

Hope may be on the horizon for neurological diseases with few or no treatment options. By harnessing RNA interference (RNAi), researchers are exploring ways to silence diseases, offering a potential new approach to conditions like Alzheimer’s disease and Huntington’s disease. Alnylam’s efforts to tackle neurological diseases have already led to promising discoveries. Now, clinical trials of investigational #RNAiTherapeutics are underway to assess their potential to treat devastating brain diseases. Read more about the science and the people driving it forward: https://bit.ly/4gV8Zgl #NeurologicalDiseases #GeneSilencing #RNAi